These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1523192)

  • 21. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system.
    Wu D; Song BW; Vinters HV; Pardridge WM
    J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
    Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery of a peptide radiopharmaceutical to brain with an IgG-avidin fusion protein.
    Zhou QH; Lu JZ; Hui EK; Boado RJ; Pardridge WM
    Bioconjug Chem; 2011 Aug; 22(8):1611-8. PubMed ID: 21707084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
    Jeong Lee H; Pardridge WM
    J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
    Johnsen KB; Moos T
    J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood-brain barrier and new approaches to brain drug delivery.
    Pardridge WM; Boado RJ; Black KL; Cancilla PA
    West J Med; 1992 Mar; 156(3):281-6. PubMed ID: 1595245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-Appended BBB-Targeted Nanocarriers (LABTNs).
    Jain A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2015; 32(2):149-80. PubMed ID: 25955883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system.
    Zhang Y; Pardridge WM
    Stroke; 2001 Jun; 32(6):1378-84. PubMed ID: 11387502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells.
    Hudecz D; Sigurdardóttir SB; Christensen SC; Hempel C; Urquhart AJ; Andresen TL; Nielsen MS
    PLoS One; 2021; 16(4):e0249686. PubMed ID: 33798235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS.
    Boado RJ; Tsukamoto H; Pardridge WM
    J Pharm Sci; 1998 Nov; 87(11):1308-15. PubMed ID: 9811482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system.
    Wu D; Pardridge WM
    J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-mediated transport of therapeutics across the blood-brain barrier.
    Friden PM
    Neurosurgery; 1994 Aug; 35(2):294-8; discussion 298. PubMed ID: 7969837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.
    Pardridge WM; Boado RJ; Kang YS
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5592-6. PubMed ID: 7777554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Strategies for drug delivery to the brain across the blood-brain barrier].
    Tsuji A
    Nihon Rinsho; 1998 Mar; 56(3):613-8. PubMed ID: 9549345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor-mediated therapeutic transport across the blood-brain barrier.
    Wang YY; Lui PC; Li JY
    Immunotherapy; 2009 Nov; 1(6):983-93. PubMed ID: 20635914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.